Table 1

Total Patients referred to SACEP

127

Patients Eligible and referred for Plasma Viral Load (PVL) (n = 127)

122(96.06%)

Patients recommended 2^nd Line ART after PVL (n = 122)

75(61.47%)

Patients initiated Free 2^nd Line ART (n = 75)

69(92.0%)

Patients under follow up TB Treatment/Counseling to initiate 2^nd Line ART

6

Adherence Counseling for 2^nd Line ART Patients (n = 69)

69(100%)

Undetectable PVL (<400 copies/ml) after 6 months of 2^nd Line ART (n = 28)

24

Therapeutic Success according to Undetectable PVL (24/28)

85.74%

No. of Death after initiation of 2^nd Line ART (n = 69)

8(11.59%)

Death Analysis

Cause of Death

WHO Stage/PVL/CD4

n = 8

Accidental

T3/560459/17

1

Renal Failure

T3/208048/230

1

Malignancy

T4/384469/38

1

Opportunistic Infections (OIs)

T3/46453/67

4

T4/507495/26

T4/1166325/32

T4/289375/21

Unknown Reason

T3/4095718/29

1